ACTO - empresa destacada en "Innovation Watch: Agentic AI in Life Sciences Commercial 2026" de Everest Group

Positive

AI Analysis

Summary

ACTO was recognized as a featured company in Everest Group's 'Innovation Watch: Agentic AI in Life Sciences Commercial 2026' report. The recognition highlights ACTO's role-based superagents, multi-platform orchestration, and governed AI approach.

Importance:2/10

Sentiment:

0.60

AIrecognitioncommerciallife sciences

Read the original article

Published by PR Newswire Biotech on October 5, 2026 12:30 PM

Read Original